YARKONA, Israel, January 4, 2018 /PRNewswire/ --
Digital diabetes platform provider GlucoMe announced today that
Under the terms of this exclusive strategic agreement, hundreds of thousands of Apollo Sugar Clinic patients will receive a "Diabetes Home-Care Kit" that includes GlucoMe's wireless blood glucose monitor, which, among other deliverables, provides real-time data to both patient and medical professional as well as continuous communication between the clinic and its patients. The combination helps to optimize treatment plans in a timely manner, which leads to better patient outcomes.
"For the first time in India, the diabetes clinic is walking into someone's house," said Dr. Prathap C. Reddy, Chairman, Apollo Hospitals Group.
Apollo Sugar Clinics CEO Gagan Bhalla said, "Diabetes is an enormous health problem challenging India's population and economy. Our goal in treating the diabetes pandemic is to achieve efficient management of the condition to result in significant improvement in overall patient health and reduce diabetes complications. We are thrilled to be introducing the GlucoMe platform in India and anticipate this to be a successful and long-term partnership."
"Apollo Sugar's advanced 'in-clinic and beyond' approach to managing diabetes promises successful nationwide implementation of the GlucoMe solution. We look forward to a productive partnership that will benefit thousands of diabetes patients and clinics across India," said GlucoMe CEO, Yiftah Ben-Aharon.
The GlucoMe solution simplifies diabetes management and lessens the burden of diabetes monitoring for medical teams and patients. It makes it easier for diabetes clinics to provide more efficient and when necessary, immediate care, by enabling digital and/or face-to-face intervention for the right patients at the right time, based on real-time information, timely alerts and continuous communication. For patients, it reinforces self-care behavior, with less overhead and greater insights.
This is how it works: The solution's wireless blood glucose monitor automatically records blood glucose measurements and insulin intakes. Data is then seamlessly transferred to the patient's smartphone, stored in a personal profile by the mobile app, and analyzed by GlucoMe's cloud-based Digital Diabetes Clinic, which also provides personalized reports and real-time alerts. In addition, the solution recommends proactive treatment approaches to be considered by the attending medical professional. The result: increased patient compliance, reduced HbA1c levels, and improved overall quality of life.
India has been described as the diabetes capital of the world. More than 69 million people, or 8.7 % of the adult population in India, are living with diabetes. According to the International Diabetes Foundation, 79.4 million people in India will have diabetes by 2030.
About Apollo Sugar Apollo Sugar, Apollo Hospitals Group's flagship chain of innovative single specialty clinics, is committed solely to providing world class care for diabetics in India. As an integral part of the Apollo Group, Asia's foremost integrated healthcare services provider with thirty years' legacy of progressing healthcare in India, Apollo Sugar has 55 clinics located across India and has the largest network of doctors and over 150 dieticians providing treatment to more than 200,000 diabetes patients. Apollo Sugar focuses on three pillars of holistic care that includes clinical research, technology support and lifestyle modification. http://www.apollosugar.com
About GlucoMe GlucoMe is a digital health company developing and marketing a comprehensive digital diabetes care solution that streamlines and simplifies diabetes care for patients, caregivers, and medical professionals. The GlucoMe platform includes: affordable wireless blood glucose and insulin pen monitors which uniquely work with audio connectivity, a mobile app compatible with iOS and Android devices, and a Digital Diabetes Clinic, which includes a cloud-based diabetes management software for healthcare professionals. The GlucoMe solution has a CE mark. FDA clearance is anticipated in 2018. Several clinical trials of the platform are ongoing worldwide. http://www.glucome.com Follow us on LinkedIn and Facebook. For more information, press requests for a GlucoMe demonstration kit or for a demonstration of the Digital Diabetes Clinic:
Press Contact: Marjie Hadad MH Communications On behalf of GlucoMe +972-54-536-5220 firstname.lastname@example.org
Subscribe to our Free Newsletters!
Abruptio placenta is a serious but rare complication of pregnancy where a separation of placenta ...
Cyanosis is the bluish or purplish discoloration of the skin and mucus membranes due to lack of ...
Find out about travel shots or vaccination before you travel to your destination country. Travel ...View All